Trait centric view

1. Trait name:	Fat percentage
   Ontology terms:	LPT:0000054

   5 genes are associated with this trait, with QTL/association found

   • FTO: Fat mass and obesity associated
     evidenced by: QTL:95231;
   • MSTN: Myostatin
     evidenced by: QTL:11886;
   • PDE1B: Phosphodiesterase 1B, calmodulin-dependent
     evidenced by: QTL:18429;
   • PRNP: Prion protein
     evidenced by: QTL:1360;
   • SCAMP2: Secretory carrier membrane protein 2
     evidenced by: QTL:25138; QTL:25139;
   102 correlations are found involving Fat percentage
    

2. Trait name:	Intermuscular fat percentage
   Ontology terms:	VT:1000465, LPT:0000099

   6 genes are associated with this trait, with QTL/association found

   • BCL6: B-cell CLL/lymphoma 6
     evidenced by: QTL:25125;
   • ESD: Esterase D
     evidenced by: QTL:25134;
   • LOC538378: Low density lipoprotein-related protein 1B
     evidenced by: QTL:25128;
   • LOC614882: Coiled-coil domain-containing protein 115-like
     evidenced by: QTL:25126;
   • MSTN: Myostatin
     evidenced by: QTL:11885;
   • PKD2: Polycystic kidney disease 2 (autosomal dominant)
     evidenced by: QTL:25132;
   10 correlations are found involving Intermuscular fat percentage
    

3. Trait name:	Kidney, pelvic, and heart fat percentage
   Ontology terms:	VT:1000130

   1 gene are associated with this trait, with QTL/association found

   • NCAM1: Neural cell adhesion molecule 1
     evidenced by: QTL:1319;
   138 correlations are found involving Kidney, pelvic, and heart fat percentage
    

4. Trait name:	Milk fat percentage
   Ontology terms:	VT:0010261, LPT:1000161, CMO:0000816

   406 genes are associated with this trait, with QTL/association found

   • A2ML1: Alpha-2-macroglobulin like 1
     evidenced by: QTL:173558;
   • AAK1: AP2 associated kinase 1
     evidenced by: QTL:34446;
   • AASDHPPT: Aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
     evidenced by: QTL:175831;
   • ABCC9: ATP binding cassette subfamily C member 9
     evidenced by: QTL:173466; QTL:173467; QTL:173468;
   • ABCG2: ATP-binding cassette, sub-family G (WHITE), member 2
     evidenced by: QTL:10489; QTL:140389; QTL:20647;
   • ABHD2: Abhydrolase domain containing 2, acylglycerol lipase
     evidenced by: QTL:51093;
   • ACACB: Acetyl-CoA carboxylase beta
     evidenced by: QTL:153262; QTL:153266; QTL:153274; QTL:153281; QTL:153289; QTL:153292; QTL:153296; QTL:153300; QTL:153304; QTL:153309; QTL:153315; QTL:153322; QTL:153329; QTL:153337; QTL:153367; QTL:153370; QTL:153386; QTL:153389; QTL:153398; QTL:153402; QTL:153406; QTL:153412; QTL:153416; QTL:153420; QTL:153424;
   • ACADVL: Acyl-CoA dehydrogenase very long chain
     evidenced by: QTL:282761; QTL:282765; QTL:282771; QTL:282776; QTL:282780; QTL:282783; QTL:282787; QTL:282791; QTL:282794; QTL:282800; QTL:282804;
   • ACO2: Aconitase 2, mitochondrial
     evidenced by: QTL:16164;
   • ACOXL: Acyl-CoA oxidase like
     evidenced by: QTL:45077;
   • ADAM2: ADAM metallopeptidase domain 2
     evidenced by: QTL:53539;
   • ADAMTS12: ADAM metallopeptidase with thrombospondin type 1 motif 12
     evidenced by: QTL:173947;
   • ADGRB1: Adhesion G protein-coupled receptor B1
     evidenced by: QTL:161664; QTL:166971; QTL:173624; QTL:173625; QTL:173626; QTL:173627; QTL:33165; QTL:33224; QTL:33374; QTL:34153; QTL:34186;
   • AGO2: Argonaute 2, RISC catalytic component
     evidenced by: QTL:161675; QTL:161676; QTL:161677; QTL:161678; QTL:161679; QTL:166980; QTL:166995; QTL:173663; QTL:173664; QTL:33016; QTL:33115; QTL:33116; QTL:33117; QTL:33204; QTL:33550; QTL:34970; QTL:34971;
   • AGPAT6: 1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta)
     evidenced by: QTL:136288; QTL:140411; QTL:214774; QTL:214858; QTL:30786; QTL:30787;
   • ALDH18A1: Aldehyde dehydrogenase 18 family member A1
     evidenced by: QTL:261671; QTL:261674; QTL:261691; QTL:261695;
   • ALDH5A1: Aldehyde dehydrogenase 5 family member A1
     evidenced by: QTL:52231;
   • ANKFN1: Ankyrin repeat and fibronectin type III domain containing 1
     evidenced by: QTL:50009;
   • ANKRD17: Ankyrin repeat domain 17
     evidenced by: QTL:42310;
   • ANTXR1: ANTXR cell adhesion molecule 1
     evidenced by: QTL:35040;
   • APBA1: Amyloid beta (A4) precursor protein-binding, family A, member 1
     evidenced by: QTL:16239;
   • APBB2: Amyloid beta precursor protein binding family B member 2
     evidenced by: QTL:33883; QTL:42045;
   • APLF: Aprataxin and PNKP like factor
     evidenced by: QTL:35103;
   • ARHGAP25: Rho GTPase activating protein 25
     evidenced by: QTL:34418;
   • ARHGAP26: Rho GTPase activating protein 26
     evidenced by: QTL:43060; QTL:43077;
   • ARHGAP39: Rho GTPase activating protein 39
     evidenced by: QTL:161665; QTL:166964; QTL:173579; QTL:32790; QTL:33363;
   • ARHGEF9: Cdc42 guanine nucleotide exchange factor 9
     evidenced by: QTL:54836;
   • ARID5B: AT rich interactive domain 5B (MRF1-like)
     evidenced by: QTL:16205;
   • ARPIN: Actin related protein 2/3 complex inhibitor
     evidenced by: QTL:51112;
   • ARRB1: Arrestin beta 1
     evidenced by: QTL:173815;
   • ASB5: Ankyrin repeat and SOCS box containing 5
     evidenced by: QTL:53317;
   • ATP1B2: ATPase, Na+/K+ transporting, beta 2 polypeptide
     evidenced by: QTL:14126;
   • AURKA: Aurora kinase A
     evidenced by: QTL:47314;
   • AURKB: Aurora kinase B
     evidenced by: QTL:215097;
   • BAIAP2: BAI1-associated protein 2
     evidenced by: QTL:16260;
   • BCAT1: Branched chain amino-acid transaminase 1, cytosolic
     evidenced by: QTL:16168;
   • BCL2L14: BCL2 like 14
     evidenced by: QTL:173544;
   • BRINP3: Bone morphogenetic protein/retinoic acid inducible neural-specific 3
     evidenced by: QTL:57258;
   • BTN1A1: Butyrophilin, subfamily 1, member A1
     evidenced by: QTL:136282;
   • BYSL: Bystin like
     evidenced by: QTL:175836;
   • C1R: Complement C1r
     evidenced by: QTL:173561;
   • C4A: Complement component 4A
     evidenced by: QTL:19989;
   • C6: Complement C6
     evidenced by: QTL:173896; QTL:173897;
   • C7: Complement C7
     evidenced by: QTL:173899; QTL:173900;
   • CACHD1: Cache domain containing 1
     evidenced by: QTL:39959;
   • CACNG5: Calcium voltage-gated channel auxiliary subunit gamma 5
     evidenced by: QTL:50269;
   • CADPS2: Calcium dependent secretion activator 2
     evidenced by: QTL:40622;
   • CAPN14: Calpain 14
     evidenced by: QTL:34921; QTL:34922; QTL:34923; QTL:34924; QTL:34925; QTL:34945; QTL:34946; QTL:34947; QTL:34973;
   • CCDC141: Coiled-coil domain containing 141
     evidenced by: QTL:39047;
   • CCDC57: Coiled-coil domain containing 57
     evidenced by: QTL:173835; QTL:173836; QTL:214764; QTL:214848;
   • CCDC69: Coiled-coil domain containing 69
     evidenced by: QTL:43216;
   • CCDC91: Coiled-coil domain containing 91
     evidenced by: QTL:36323; QTL:41327;
   • CCL28: C-C motif chemokine ligand 28
     evidenced by: QTL:173868;
   • CCN4: Cellular communication network factor 4
     evidenced by: QTL:173767;
   • CCNB1: Cyclin B1
     evidenced by: QTL:16265;
   • CCND3: Cyclin D3
     evidenced by: QTL:175837;
   • CD2: CD2 molecule
     evidenced by: QTL:57255;
   • CD4: CD4 molecule
     evidenced by: QTL:122136;
   • CD9: CD9 molecule
     evidenced by: QTL:41559;
   • CDC42BPA: CDC42 binding protein kinase alpha
     evidenced by: QTL:173567;
   • CDH2: Cadherin 2
     evidenced by: QTL:180615;
   • CDKN1A: Cyclin dependent kinase inhibitor 1A
     evidenced by: QTL:135560; QTL:135570; QTL:135588;
   • CERS6: Ceramide synthase 6
     evidenced by: QTL:39104;
   • CHRM3: Cholinergic receptor muscarinic 3
     evidenced by: QTL:53730;
   • CLEC2B: C-type lectin domain family 2, member B
     evidenced by: QTL:173554;
   • CLU: Clusterin
     evidenced by: QTL:18795;
   • CNTN5: Contactin 5
     evidenced by: QTL:47781;
   • COL22A1: Collagen type XXII alpha 1 chain
     evidenced by: QTL:173700; QTL:173701; QTL:173702; QTL:173703; QTL:173704; QTL:173705; QTL:32939; QTL:32940; QTL:32941; QTL:32942; QTL:32943; QTL:32944; QTL:32945; QTL:32946; QTL:33018; QTL:33019; QTL:33020; QTL:33021; QTL:33022; QTL:33023; QTL:33024; QTL:33025; QTL:33026; QTL:33027; QTL:33028; QTL:33071; QTL:33287; QTL:33288; QTL:33289; QTL:33352; QTL:33420; QTL:33446; QTL:33474; QTL:33564; QTL:33576; QTL:33577; QTL:33583; QTL:33584; QTL:33585; QTL:33586; QTL:33603; QTL:33604; QTL:33608; QTL:33707; QTL:33944; QTL:34438; QTL:34439; QTL:34440; QTL:34441; QTL:34442; QTL:34443; QTL:34444; QTL:34477; QTL:34491; QTL:34492; QTL:34493; QTL:34494; QTL:34495; QTL:34496; QTL:34497; QTL:34524; QTL:34535; QTL:34545; QTL:34556; QTL:34557; QTL:34621; QTL:34622; QTL:34659;
   • COL4A4: Collagen type IV alpha 4 chain
     evidenced by: QTL:39573;
   • COL4A6: Collagen type IV alpha 6 chain
     evidenced by: QTL:54591;
   • COL6A1: Collagen type VI alpha 1 chain
     evidenced by: QTL:38932;
   • CPA5: Carboxypeptidase A5
     evidenced by: QTL:40660;
   • CPQ: Carboxypeptidase Q
     evidenced by: QTL:173804; QTL:173805; QTL:173806;
   • CPSF1: Cleavage and polyadenylation specific factor 1, 160kDa
     evidenced by: QTL:285907; QTL:32795; QTL:34084; QTL:57256;
   • CRACR2A: Calcium release activated channel regulator 2A
     evidenced by: QTL:173563;
   • CREBL2: CAMP responsive element binding protein like 2
     evidenced by: QTL:173538;
   • CSAD: Cysteine sulfinic acid decarboxylase
     evidenced by: QTL:40829;
   • CSGALNACT1: Chondroitin sulfate N-acetylgalactosaminyltransferase 1
     evidenced by: QTL:53590;
   • CSMD2: CUB and Sushi multiple domains 2
     evidenced by: QTL:33798;
   • CSN1S1: Casein alpha s1
     evidenced by: QTL:136198; QTL:140390;
   • CSN2: Casein beta
     evidenced by: QTL:10469;
   • CSN@: Casein (cluster)
     evidenced by: QTL:2595;
   • CSTF3: Cleavage stimulation factor subunit 3
     evidenced by: QTL:173822;
   • CTNNA3: Catenin alpha 3
     evidenced by: QTL:53761;
   • CUL3: Cullin 3
     evidenced by: QTL:39542;
   • CYHR1: Cysteine and histidine rich 1
     evidenced by: QTL:161670; QTL:166932; QTL:173581; QTL:285917; QTL:32793; QTL:33008; QTL:33009; QTL:33010;
   • CYP27A1: Cytochrome P450, family 27, subfamily A, polypeptide 1
     evidenced by: QTL:16148;
   • DAB2: DAB2, clathrin adaptor protein
     evidenced by: QTL:173914;
   • DACH1: Dachshund family transcription factor 1
     evidenced by: QTL:46324;
   • DCUN1D1: Defective in cullin neddylation 1 domain containing 1
     evidenced by: QTL:38492;
   • DDIT3: DNA damage inducible transcript 3
     evidenced by: QTL:168858; QTL:168860; QTL:168862; QTL:168864; QTL:169685; QTL:169687;
   • DENND3: DENN domain containing 3
     evidenced by: QTL:173649; QTL:33112;
   • DERA: Deoxyribose-phosphate aldolase
     evidenced by: QTL:173504;
   • DGAT1: Diacylglycerol O-acyltransferase 1
     evidenced by: QTL:10263; QTL:10402; QTL:10407; QTL:10581; QTL:10608; QTL:10609; QTL:121762; QTL:121767; QTL:12216; QTL:126976; QTL:126977; QTL:126978; QTL:130482; QTL:130497; QTL:130514; QTL:139269; QTL:140396; QTL:161672; QTL:166925; QTL:167555; QTL:173583; QTL:175825; QTL:19001; QTL:214747; QTL:214834; QTL:214837; QTL:215048; QTL:24999; QTL:285905; QTL:30778; QTL:30784; QTL:31661; QTL:31666; QTL:32796; QTL:34035; QTL:3510; QTL:3515; QTL:36322; QTL:47447; QTL:95648;
   • DGKG: Diacylglycerol kinase gamma
     evidenced by: QTL:136180;
   • DHX32: DEAH-box helicase 32 (putative)
     evidenced by: QTL:53091;
   • DIP2C: Disco interacting protein 2 homolog C
     evidenced by: QTL:34294; QTL:34375; QTL:34376; QTL:34377; QTL:34378; QTL:34379;
   • DOCK1: Dedicator of cytokinesis 1
     evidenced by: QTL:53110;
   • DOCK5: Dedicator of cytokinesis 5
     evidenced by: QTL:43684;
   • DOK6: Docking protein 6
     evidenced by: QTL:52286;
   • DPP10: Dipeptidyl peptidase like 10
     evidenced by: QTL:175822;
   • EBF1: EBF transcription factor 1
     evidenced by: QTL:43246;
   • EEF1D: Eukaryotic translation elongation factor 1 delta
     evidenced by: QTL:161673; QTL:166970; QTL:173601;
   • EFNA1: Ephrin A1
     evidenced by: QTL:173452;
   • EFR3A: EFR3 homolog A
     evidenced by: QTL:173776; QTL:173777; QTL:173778;
   • EGF: Epidermal growth factor
     evidenced by: QTL:41922;
   • EGFLAM: EGF like, fibronectin type III and laminin G domains
     evidenced by: QTL:173921; QTL:173922; QTL:173923;
   • ELOVL6: ELOVL fatty acid elongase 6
     evidenced by: QTL:161548;
   • EMB: Embigin
     evidenced by: QTL:173840; QTL:173841;
   • EMP1: Epithelial membrane protein 1
     evidenced by: QTL:173532;
   • ENTHD1: ENTH domain containing 1
     evidenced by: QTL:41606;
   • EPB41L2: Erythrocyte membrane protein band 4.1 like 2
     evidenced by: QTL:44096;
   • EPHA6: EPH receptor A6
     evidenced by: QTL:215042;
   • EPPK1: Epiplakin 1
     evidenced by: QTL:173594; QTL:33476; QTL:34434;
   • EPS8: Epidermal growth factor receptor pathway substrate 8
     evidenced by: QTL:173508; QTL:173509; QTL:173510; QTL:173511; QTL:173512; QTL:30777; QTL:30782; QTL:30783; QTL:65672;
   • ERBB2: Erb-b2 receptor tyrosine kinase 2
     evidenced by: QTL:167476;
   • ERCC6L2: ERCC excision repair 6 like 2
     evidenced by: QTL:173565;
   • ETS2: ETS proto-oncogene 2, transcription factor
     evidenced by: QTL:136176;
   • ETV6: ETS variant 6
     evidenced by: QTL:173546;
   • EXT1: Exostosin glycosyltransferase 1
     evidenced by: QTL:47618;
   • FA2H: Fatty acid 2-hydroxylase
     evidenced by: QTL:49437;
   • FABP4: Fatty acid binding protein 4, adipocyte
     evidenced by: QTL:102201; QTL:102207;
   • FADS2: Fatty acid desaturase 2
     evidenced by: QTL:256851; QTL:256865; QTL:256875; QTL:256892; QTL:256901; QTL:256908; QTL:256915; QTL:256928; QTL:256933;
   • FAM134B: Family with sequence similarity 134 member B
     evidenced by: QTL:50910;
   • FAM135B: Family with sequence similarity 135 member B
     evidenced by: QTL:173707; QTL:173708; QTL:173709; QTL:173710; QTL:173711; QTL:173712; QTL:173713; QTL:33076; QTL:33150; QTL:33189; QTL:33190; QTL:33191; QTL:33202; QTL:33203; QTL:33209; QTL:33210; QTL:33214; QTL:33218; QTL:33230; QTL:33231; QTL:33232; QTL:33233; QTL:33234; QTL:33245; QTL:33268; QTL:33270; QTL:33314; QTL:33331; QTL:33350; QTL:33364; QTL:33365; QTL:33366; QTL:33367; QTL:33368; QTL:33436; QTL:33437; QTL:33486; QTL:33487; QTL:33488; QTL:33519; QTL:33520; QTL:33529; QTL:33548; QTL:33549; QTL:33627; QTL:33790; QTL:33850; QTL:33876; QTL:33877; QTL:33878; QTL:34188; QTL:34189; QTL:34190; QTL:34256; QTL:34280; QTL:34281; QTL:34282; QTL:34323; QTL:34338; QTL:34339; QTL:34340; QTL:34576; QTL:34586; QTL:34674; QTL:34974;
   • FAM13A: Family with sequence similarity 13, member A
     evidenced by: QTL:10496;
   • FAM83H: Family with sequence similarity 83 member H
     evidenced by: QTL:32869; QTL:34620;
   • FASN: Fatty acid synthase
     evidenced by: QTL:10433; QTL:10434; QTL:11497; QTL:140406; QTL:173837; QTL:28090;
   • FBLN5: Fibulin 5
     evidenced by: QTL:51388;
   • FCGR2: Fc fragment of IgG, low affinity IIb, receptor (CD32)
     evidenced by: QTL:2594;
   • FHIT: Fragile histidine triad diadenosine triphosphatase
     evidenced by: QTL:51734;
   • FP: Milk fat percentage
     evidenced by: QTL:2652;
   • FRMD5: FERM domain containing 5
     evidenced by: QTL:51343;
   • FUT10: Fucosyltransferase 10
     evidenced by: QTL:53465;
   • FYB: FYN binding protein
     evidenced by: QTL:173917;
   • GABARAPL1: GABA(A) receptor-associated protein like 1
     evidenced by: QTL:16173; QTL:173553; QTL:41519;
   • GARIN2: Golgi associated RAB2 interactor family member 2
     evidenced by: QTL:44953;
   • GBA: Glucosidase, beta, acid
     evidenced by: QTL:173451;
   • GDNF: Glial cell derived neurotrophic factor
     evidenced by: QTL:173929;
   • GH1: Growth hormone 1
     evidenced by: QTL:14082; QTL:14083; QTL:14084; QTL:136264;
   • GHR: Growth hormone receptor
     evidenced by: QTL:121744; QTL:121748; QTL:12969; QTL:12970; QTL:12971; QTL:12972; QTL:12973; QTL:140407; QTL:161685; QTL:161686; QTL:161687; QTL:161688; QTL:166981; QTL:166986; QTL:173872; QTL:173873; QTL:173874; QTL:173875; QTL:173876; QTL:175833; QTL:214855; QTL:30785; QTL:36326; QTL:5632; QTL:5633; QTL:9981;
   • GINS4: GINS complex subunit 4 (Sld5 homolog)
     evidenced by: QTL:173953; QTL:25002;
   • GLI4: GLI family zinc finger 4
     evidenced by: QTL:32897;
   • GML: Glycosylphosphatidylinositol anchored molecule like
     evidenced by: QTL:161689; QTL:173614; QTL:173615; QTL:33216; QTL:47437;
   • GNAS: GNAS complex locus
     evidenced by: QTL:16138;
   • GPIHBP1: Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
     evidenced by: QTL:139268;
   • GPR20: G protein-coupled receptor 20
     evidenced by: QTL:173644;
   • GRHL2: Grainyhead like transcription factor 2
     evidenced by: QTL:173788; QTL:173789;
   • GRHL3: Grainyhead like transcription factor 3
     evidenced by: QTL:173446;
   • GRIA4: Glutamate ionotropic receptor AMPA type subunit 4
     evidenced by: QTL:175832;
   • GRIN2B: Glutamate ionotropic receptor NMDA type subunit 2B
     evidenced by: QTL:173525; QTL:173526;
   • GSDMD: Gasdermin D
     evidenced by: QTL:32832; QTL:34167;
   • GSG1: Germ cell associated 1
     evidenced by: QTL:173537;
   • GSK3A: Glycogen synthase kinase 3 alpha
     evidenced by: QTL:49682;
   • GUCY2C: Guanylate cyclase 2C
     evidenced by: QTL:173521;
   • HCN1: Hyperpolarization activated cyclic nucleotide gated potassium channel 1
     evidenced by: QTL:173845; QTL:173846; QTL:173847; QTL:173848; QTL:173849; QTL:173850; QTL:173851; QTL:175834;
   • HERC5: HECT and RLD domain containing E3 ubiquitin protein ligase 5
     evidenced by: QTL:214822;
   • HERC6: Hect domain and RLD 6
     evidenced by: QTL:10493; QTL:214738;
   • HPCAL1: Hippocalcin like 1
     evidenced by: QTL:45966;
   • HPSE2: Heparanase 2 (inactive)
     evidenced by: QTL:52751; QTL:52762; QTL:52775;
   • HS6ST3: Heparan sulfate 6-O-sulfotransferase 3
     evidenced by: QTL:285919;
   • HSD17B3: Hydroxysteroid (17-beta) dehydrogenase 3
     evidenced by: QTL:57259;
   • HSF1: Heat shock transcription factor 1
     evidenced by: QTL:167554;
   • HSPA8: Heat shock protein family A (Hsp70) member 8
     evidenced by: QTL:167456;
   • IDH1: Isocitrate dehydrogenase 1 (NADP+), soluble
     evidenced by: QTL:16154;
   • IDH2: Isocitrate dehydrogenase (NADP(+)) 2
     evidenced by: QTL:315664; QTL:315672; QTL:315678;
   • IFIH1: Interferon induced with helicase C domain 1
     evidenced by: QTL:16213;
   • IGF1: Insulin-like growth factor 1 (somatomedin C)
     evidenced by: QTL:13036; QTL:20624;
   • IGF1R: Insulin-like growth factor 1 receptor
     evidenced by: QTL:122209;
   • IGF2: Insulin-like growth factor 2 (somatomedin A)
     evidenced by: QTL:13048; QTL:13049; QTL:13050;
   • IGFBP2: Insulin-like growth factor binding protein 2, 36kDa
     evidenced by: QTL:16217;
   • IGFBP7: Insulin-like growth factor binding protein 7
     evidenced by: QTL:16235;
   • IL1RAPL2: Interleukin 1 receptor accessory protein-like 2
     evidenced by: QTL:54535;
   • IQANK1: IQ motif and ankyrin repeat containing 1
     evidenced by: QTL:173598; QTL:47451;
   • IRF6: Interferon regulatory factor 6
     evidenced by: QTL:282806; QTL:282809; QTL:282818; QTL:282823; QTL:282826; QTL:282830; QTL:282833; QTL:282838; QTL:282841; QTL:282846; QTL:282849; QTL:282854; QTL:282858; QTL:282863;
   • IRF9: Interferon regulatory factor 9
     evidenced by: QTL:16245;
   • ITGB1BP1: Integrin subunit beta 1 binding protein 1
     evidenced by: QTL:46029;
   • ITPK1: Inositol-tetrakisphosphate 1-kinase
     evidenced by: QTL:51420;
   • ITPR2: Inositol 1,4,5-trisphosphate receptor, type 2
     evidenced by: QTL:173453; QTL:36325;
   • ITSN2: Intersectin 2
     evidenced by: QTL:35097;
   • KCNIP4: Kv channel interacting protein 4
     evidenced by: QTL:33630; QTL:33768; QTL:33769; QTL:33770; QTL:33958;
   • KCNK9: Potassium two pore domain channel subfamily K member 9
     evidenced by: QTL:161699; QTL:161700; QTL:166978; QTL:173680; QTL:173681; QTL:173682; QTL:32881; QTL:32882; QTL:32883; QTL:32884; QTL:32912; QTL:33015; QTL:33103; QTL:33380;
   • KCNQ3: Potassium voltage-gated channel subfamily Q member 3
     evidenced by: QTL:125187; QTL:173773; QTL:173774; QTL:173775;
   • KDM4C: Lysine demethylase 4C
     evidenced by: QTL:43616; QTL:43625; QTL:43634;
   • KDM6A: Lysine demethylase 6A
     evidenced by: QTL:54874;
   • KHDRBS2: KH RNA binding domain containing, signal transduction associated 2
     evidenced by: QTL:51871;
   • KHDRBS3: KH domain containing, RNA binding, signal transduction associated 3
     evidenced by: QTL:161701; QTL:161702; QTL:173745; QTL:173746; QTL:173747; QTL:173748; QTL:173749; QTL:33514; QTL:33515; QTL:33704; QTL:33705;
   • KLF6: KLF transcription factor 6
     evidenced by: QTL:314330; QTL:314335; QTL:314339; QTL:314344; QTL:314347; QTL:314352; QTL:314365; QTL:314370; QTL:314378; QTL:314383; QTL:314387; QTL:314395; QTL:314400; QTL:314405; QTL:314416; QTL:314421;
   • KLHL41: Kelch-like family member 41
     evidenced by: QTL:36327;
   • KMT2A: Lysine methyltransferase 2A
     evidenced by: QTL:47840;
   • KSR2: Kinase suppressor of ras 2
     evidenced by: QTL:16250;
   • LALBA: Lactalbumin, alpha-
     evidenced by: QTL:238152;
   • LAP3: Leucine aminopeptidase 3
     evidenced by: QTL:10478; QTL:16057;
   • LDHB: Lactate dehydrogenase B
     evidenced by: QTL:315686; QTL:315689; QTL:315694;
   • LEP: Leptin
     evidenced by: QTL:13025; QTL:13026; QTL:13027;
   • LGMN: Legumain
     evidenced by: QTL:16194;
   • LIPA: Lipase A, lysosomal acid, cholesterol esterase
     evidenced by: QTL:16201;
   • LOC100299242: Ankyrin repeat domain-containing protein 26-like
     evidenced by: QTL:173572;
   • LOC100299732: Testis-expressed protein 19.2
     evidenced by: QTL:173833;
   • LOC100848575: Killer cell lectin-like receptor subfamily E member 1
     evidenced by: QTL:173552;
   • LOC100848939: Uncharacterized LOC100848939
     evidenced by: QTL:173618; QTL:173619;
   • LOC101901918: Uncharacterized LOC101901918
     evidenced by: QTL:173637;
   • LOC101908561: Uncharacterized LOC101908561
     evidenced by: QTL:173559;
   • LOC104972567: Uncharacterized LOC104972567
     evidenced by: QTL:173562;
   • LOC104975271: Uncharacterized LOC104975271
     evidenced by: QTL:173904;
   • LOC104975277: Uncharacterized LOC104975277
     evidenced by: QTL:173925; QTL:173926; QTL:173927;
   • LOC107131524: Uncharacterized LOC107131524
     evidenced by: QTL:173830;
   • LOC107133100: Uncharacterized LOC107133100
     evidenced by: QTL:173761;
   • LOC787628: Cytochrome P450 11B1, mitochondrial
     evidenced by: QTL:173613; QTL:33215;
   • LOC789384: Zinc finger protein 250
     evidenced by: QTL:33168;
   • LPIN1: Lipin 1
     evidenced by: QTL:170542; QTL:170544; QTL:170551; QTL:170553;
   • LPL: Lipoprotein lipase
     evidenced by: QTL:136235;
   • LRP6: LDL receptor related protein 6
     evidenced by: QTL:173540; QTL:173541; QTL:173542;
   • LTF: Lactotransferrin
     evidenced by: QTL:136279; QTL:95722; QTL:95726; QTL:95735;
   • LY6D: Lymphocyte antigen 6 family member D
     evidenced by: QTL:161706; QTL:166962; QTL:33308;
   • LY6E: Lymphocyte antigen 6 family member E
     evidenced by: QTL:173610; QTL:33237;
   • LY6H: Lymphocyte antigen 6 family member H
     evidenced by: QTL:32956;
   • MAF1: MAF1 homolog, negative regulator of RNA polymerase III
     evidenced by: QTL:161711; QTL:166939; QTL:173587;
   • MAML3: Mastermind like transcriptional coactivator 3
     evidenced by: QTL:48973;
   • MAN1A2: Mannosidase alpha class 1A member 2
     evidenced by: QTL:33029; QTL:33369;
   • MANSC1: MANSC domain containing 1
     evidenced by: QTL:173539;
   • MAOB: Monoamine oxidase B
     evidenced by: QTL:54916;
   • MAP4K4: Mitogen-activated protein kinase kinase kinase kinase 4
     evidenced by: QTL:130214; QTL:130215;
   • MAPK15: Mitogen-activated protein kinase 15
     evidenced by: QTL:161712; QTL:166958; QTL:173599; QTL:32903; QTL:34856;
   • MAT2A: Methionine adenosyltransferase 2A
     evidenced by: QTL:261702; QTL:261708;
   • MATN2: Matrilin 2
     evidenced by: QTL:173803;
   • MBNL3: Muscleblind like splicing regulator 3
     evidenced by: QTL:54317;
   • MCM8: Minichromosome maintenance 8 homologous recombination repair factor
     evidenced by: QTL:47127;
   • MFGE8: Milk fat globule-EGF factor 8 protein
     evidenced by: QTL:51082;
   • MGP: Matrix Gla protein
     evidenced by: QTL:16177; QTL:173518; QTL:41510;
   • MGST1: Microsomal glutathione S-transferase 1
     evidenced by: QTL:140385; QTL:167541; QTL:214732; QTL:214815; QTL:214816; QTL:214818;
   • MND1: Meiotic nuclear divisions 1
     evidenced by: QTL:48583;
   • MOCS1: Molybdenum cofactor synthesis 1
     evidenced by: QTL:175838;
   • MROH1: Maestro heat-like repeat family member 1
     evidenced by: QTL:161713; QTL:161714; QTL:161715; QTL:166929; QTL:166930; QTL:166931; QTL:173584; QTL:173585; QTL:173586; QTL:214750; QTL:214753; QTL:214831; QTL:33966; QTL:33967; QTL:33968; QTL:34036; QTL:34037; QTL:34076; QTL:34077; QTL:34078;
   • MRPL32: Mitochondrial ribosomal protein L32
     evidenced by: QTL:16161;
   • MRPS30: Mitochondrial ribosomal protein S30
     evidenced by: QTL:173860;
   • MS4A8: Membrane-spanning 4-domains, subfamily A, member 8
     evidenced by: QTL:57260;
   • MSN: Moesin
     evidenced by: QTL:54825;
   • MTMR12: Myotubularin related protein 12
     evidenced by: QTL:173951;
   • MTMR3: Myotubularin related protein 3
     evidenced by: QTL:16187;
   • MYO16: Myosin XVI
     evidenced by: QTL:34944;
   • NALCN: Sodium leak channel, non-selective
     evidenced by: QTL:46534;
   • NAPRT: Nicotinate phosphoribosyltransferase
     evidenced by: QTL:33221;
   • NBAS: NBAS subunit of NRZ tethering complex
     evidenced by: QTL:45724;
   • NCKAP5: NCK-associated protein 5
     evidenced by: QTL:175823;
   • NCSTN: Nicastrin
     evidenced by: QTL:39715;
   • NFAM1: NFAT activating protein with ITAM motif 1
     evidenced by: QTL:41674;
   • NFIB: Nuclear factor I/B
     evidenced by: QTL:36329;
   • NFIX: Nuclear factor I X
     evidenced by: QTL:42753; QTL:42766;
   • NGFR: Nerve growth factor receptor
     evidenced by: QTL:256235; QTL:256237; QTL:256239; QTL:256242; QTL:256244; QTL:256246; QTL:256281;
   • NHSL1: NHS like 1
     evidenced by: QTL:44139;
   • NIPBL: NIPBL, cohesin loading factor
     evidenced by: QTL:173931; QTL:173932; QTL:173933;
   • NNT: Nicotinamide nucleotide transhydrogenase
     evidenced by: QTL:173866; QTL:173867;
   • NPC1: Niemann-Pick disease, type C1
     evidenced by: QTL:16274;
   • NPR3: Natriuretic peptide receptor 3
     evidenced by: QTL:173950;
   • NR4A1: Nuclear receptor subfamily 4 group A member 1
     evidenced by: QTL:169032; QTL:169036; QTL:169040; QTL:169047; QTL:169055; QTL:169061; QTL:169068; QTL:169715;
   • NRG3: Neuregulin 3
     evidenced by: QTL:53803; QTL:53821;
   • NRSN2: Neurensin 2
     evidenced by: QTL:47327;
   • NT5DC3: 5'-nucleotidase domain containing 3
     evidenced by: QTL:41049;
   • NT5E: 5'-nucleotidase, ecto (CD73)
     evidenced by: QTL:44078;
   • NUCB2: Nucleobindin 2
     evidenced by: QTL:176531; QTL:176532; QTL:176539; QTL:176543; QTL:176549; QTL:176555; QTL:176564; QTL:176569; QTL:176575; QTL:176581; QTL:176585;
   • NUP98: Nucleoporin 98
     evidenced by: QTL:173813;
   • OAS1Z: 2',5'-oligoadenylate synthetase 1, 40/46kDa
     evidenced by: QTL:16191;
   • OCIAD2: OCIA domain containing 2
     evidenced by: QTL:33853;
   • OCLN: Occludin
     evidenced by: QTL:57261;
   • OLFM4: Olfactomedin 4
     evidenced by: QTL:33909;
   • OLR1: Oxidized low density lipoprotein (lectin-like) receptor 1
     evidenced by: QTL:11501; QTL:136185;
   • OPLAH: 5-oxoprolinase
     evidenced by: QTL:125184;
   • OSMR: Oncostatin M receptor
     evidenced by: QTL:173919;
   • OXCT1: 3-oxoacid CoA-transferase 1
     evidenced by: QTL:173886; QTL:173887; QTL:173888;
   • P4HA3: Prolyl 4-hydroxylase subunit alpha 3
     evidenced by: QTL:173814;
   • PAEP: Progestagen-associated endometrial protein
     evidenced by: QTL:10464; QTL:12406; QTL:238165;
   • PAH: Phenylalanine hydroxylase
     evidenced by: QTL:41015;
   • PARD3: Par-3 family cell polarity regulator
     evidenced by: QTL:46826; QTL:46857; QTL:46872;
   • PARP12: Poly (ADP-ribose) polymerase family, member 12
     evidenced by: QTL:16225;
   • PARP8: Poly(ADP-ribose) polymerase family member 8
     evidenced by: QTL:173839;
   • PCBD1: Pterin-4 alpha-carbinolamine dehydratase 1
     evidenced by: QTL:53777;
   • PCDHA13: Protocadherin alpha 13
     evidenced by: QTL:43044;
   • PCIF1: Phosphorylated CTD interacting factor 1
     evidenced by: QTL:47370;
   • PDE1B: Phosphodiesterase 1B, calmodulin-dependent
     evidenced by: QTL:40810;
   • PDE4D: Phosphodiesterase 4D
     evidenced by: QTL:50691; QTL:50710;
   • PDGFRB: Platelet derived growth factor receptor beta
     evidenced by: QTL:43177;
   • PEA15: Proliferation and apoptosis adaptor protein 15
     evidenced by: QTL:39730;
   • PHF20: PHD finger protein 20
     evidenced by: QTL:47337;
   • PHF20L1: PHD finger protein 20 like 1
     evidenced by: QTL:173770;
   • PHF2: PHD finger protein 2
     evidenced by: QTL:43718;
   • PIK3C2G: Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma
     evidenced by: QTL:173482; QTL:173483; QTL:173484; QTL:173485; QTL:173486; QTL:173487; QTL:173488; QTL:173489; QTL:173490;
   • PKD2: Polycystic kidney disease 2 (autosomal dominant)
     evidenced by: QTL:10484; QTL:173564;
   • PLBD1: Phospholipase B domain containing 1
     evidenced by: QTL:161748;
   • PLCE1: Phospholipase C, epsilon 1
     evidenced by: QTL:136283;
   • PLCXD3: Phosphatidylinositol specific phospholipase C X domain containing 3
     evidenced by: QTL:173891; QTL:173892;
   • PLEC: Plectin
     evidenced by: QTL:161750; QTL:166948; QTL:173592; QTL:261847; QTL:285911; QTL:285912; QTL:32821; QTL:32822; QTL:32823; QTL:32824; QTL:33419;
   • PLEK: Pleckstrin
     evidenced by: QTL:34297;
   • PLEKHA5: Pleckstrin homology domain containing A5
     evidenced by: QTL:173474; QTL:173475; QTL:173476; QTL:173477; QTL:261844;
   • PPARGC1A: Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
     evidenced by: QTL:136189;
   • PPP1R16A: Protein phosphatase 1 regulatory subunit 16A
     evidenced by: QTL:173580; QTL:175827;
   • PRKDC: Protein kinase, DNA-activated, catalytic polypeptide
     evidenced by: QTL:173786;
   • PRL: Prolactin
     evidenced by: QTL:11308; QTL:281192; QTL:281194;
   • PRLR: Prolactin receptor
     evidenced by: QTL:136272; QTL:16131; QTL:173945;
   • PRNP: Prion protein
     evidenced by: QTL:3616; QTL:3617; QTL:3618; QTL:2597; QTL:2650; QTL:2729; QTL:2549; QTL:1753; QTL:3434;
   • PRRX2: Paired related homeobox 2
     evidenced by: QTL:46103;
   • PTK2: Protein tyrosine kinase 2
     evidenced by: QTL:161754; QTL:161755; QTL:161756; QTL:161757; QTL:166959; QTL:166985; QTL:173654; QTL:173655; QTL:173656; QTL:173657; QTL:173658; QTL:173659; QTL:32867; QTL:32868; QTL:33004; QTL:33098; QTL:33099; QTL:33100; QTL:33101; QTL:33169; QTL:33170; QTL:33171; QTL:33172; QTL:33173; QTL:33246; QTL:33249; QTL:33250; QTL:33389; QTL:33390; QTL:33391; QTL:33460; QTL:33477; QTL:33657; QTL:33781; QTL:34938; QTL:47460; QTL:71146; QTL:71152; QTL:71197; QTL:71198; QTL:71201; QTL:71203; QTL:71207; QTL:71210; QTL:71212; QTL:71216; QTL:71219; QTL:71222; QTL:71225;
   • PTPRO: Protein tyrosine phosphatase, receptor type O
     evidenced by: QTL:173513; QTL:173514;
   • PTRH1: Peptidyl-tRNA hydrolase 1 homolog (S. cerevisiae)
     evidenced by: QTL:36331;
   • PYCR3: Pyrroline-5-carboxylate reductase 3
     evidenced by: QTL:32831; QTL:34127;
   • RAB4A: RAB4A, member RAS oncogene family
     evidenced by: QTL:33981;
   • RAI14: Retinoic acid induced 14
     evidenced by: QTL:173946;
   • RAI1: Retinoic acid induced 1
     evidenced by: QTL:173829;
   • RASGRP3: RAS guanyl releasing protein 3
     evidenced by: QTL:45181;
   • RERG: RAS like estrogen regulated growth inhibitor
     evidenced by: QTL:173515; QTL:173516; QTL:173517;
   • RFX4: Regulatory factor X4
     evidenced by: QTL:41096;
   • RGS22: Regulator of G-protein signaling 22
     evidenced by: QTL:173793; QTL:173794;
   • RHPN1: Rhophilin Rho GTPase binding protein 1
     evidenced by: QTL:161760; QTL:166947; QTL:173604; QTL:32856;
   • RICTOR: RPTOR independent companion of MTOR complex 2
     evidenced by: QTL:173918;
   • RNF157: Ring finger protein 157
     evidenced by: QTL:50084;
   • RNF19A: Ring finger protein 19A, RBR E3 ubiquitin protein ligase
     evidenced by: QTL:173792;
   • RPL23A: Ribosomal protein L23a
     evidenced by: QTL:168880; QTL:168883; QTL:168888; QTL:168892; QTL:168896; QTL:168899; QTL:168906; QTL:168910; QTL:168915; QTL:168938; QTL:169694;
   • RUNX2: RUNX family transcription factor 2
     evidenced by: QTL:175839;
   • SAA2: Serum amyloid A2
     evidenced by: QTL:138696; QTL:138703; QTL:139815; QTL:139818; QTL:139823;
   • SART3: Spliceosome associated factor 3, U4/U6 recycling protein
     evidenced by: QTL:49409; QTL:49414;
   • SCARB1: Scavenger receptor class B member 1
     evidenced by: QTL:125191;
   • SCD: Stearoyl-CoA desaturase (delta-9-desaturase)
     evidenced by: QTL:301216; QTL:301218; QTL:301220; QTL:301222;
   • SCRIB: Scribbled planar cell polarity protein
     evidenced by: QTL:161761; QTL:166992; QTL:173597;
   • SCRN1: Secernin 1
     evidenced by: QTL:16230;
   • SDC2: Syndecan 2
     evidenced by: QTL:173807;
   • SDR16C5: Short chain dehydrogenase/reductase family 16C, member 5
     evidenced by: QTL:18862;
   • SEC13: SEC13 homolog, nuclear pore and COPII coat complex component
     evidenced by: QTL:263585;
   • SEC24D: SEC24 homolog D, COPII coat complex component
     evidenced by: QTL:41848;
   • SEC63: SEC63 homolog, protein translocation regulator
     evidenced by: QTL:43963;
   • SERPINA14: Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 14
     evidenced by: QTL:16197;
   • SERPINA1: Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
     evidenced by: QTL:14041;
   • SERPINB5: Serpin family B member 5
     evidenced by: QTL:52454;
   • SESN2: Sestrin 2
     evidenced by: QTL:168949; QTL:168953; QTL:168958; QTL:169697;
   • SHANK2: SH3 and multiple ankyrin repeat domains 2
     evidenced by: QTL:53973;
   • SLC10A7: Solute carrier family 10 member 7
     evidenced by: QTL:48710;
   • SLC15A5: Solute carrier family 15 member 5
     evidenced by: QTL:161763; QTL:166969; QTL:173500; QTL:173501;
   • SLC1A1: Solute carrier family 1 member 1
     evidenced by: QTL:261845;
   • SLC1A3: Solute carrier family 1 member 3
     evidenced by: QTL:173938;
   • SLC25A12: Solute carrier family 25 member 12
     evidenced by: QTL:39079;
   • SLC35F6: Solute carrier family 35 member F6
     evidenced by: QTL:173571;
   • SLC45A4: Solute carrier family 45 member 4
     evidenced by: QTL:173647; QTL:173648; QTL:33340;
   • SLC52A2: Solute carrier family 52 (riboflavin transporter), member 2
     evidenced by: QTL:285906;
   • SLC8A1: Solute carrier family 8 (sodium/calcium exchanger), member 1
     evidenced by: QTL:45242; QTL:45250;
   • SLC8A3: Solute carrier family 8 member A3
     evidenced by: QTL:44964;
   • SLCO1A2: Solute carrier organic anion transporter family member 1A2
     evidenced by: QTL:41444;
   • SLCO1B3: Solute carrier organic anion transporter family member 1B3
     evidenced by: QTL:173471;
   • SLIT3: Slit guidance ligand 3
     evidenced by: QTL:50313;
   • SMCO3: Single-pass membrane protein with coiled-coil domains 3
     evidenced by: QTL:173519;
   • SMPD5: Sphingomyelin phosphodiesterase 5, pseudogene
     evidenced by: QTL:173589; QTL:175828; QTL:32810;
   • SOX5: SRY-box 5
     evidenced by: QTL:173455; QTL:173456; QTL:173457; QTL:173458; QTL:214813;
   • SPATA3: Spermatogenesis associated 3
     evidenced by: QTL:39604;
   • SPEF2: Sperm flagellar 2
     evidenced by: QTL:173941;
   • SPOCK1: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
     evidenced by: QTL:43008; QTL:43028;
   • SPP1: Secreted phosphoprotein 1
     evidenced by: QTL:10039; QTL:10115; QTL:10397; QTL:10481; QTL:13166; QTL:13167; QTL:13168; QTL:18418;
   • SREBF2: Sterol regulatory element binding transcription factor 2
     evidenced by: QTL:41618;
   • SREBP-1: Sterol regulatory element binding protein-1
     evidenced by: QTL:20082;
   • ST3GAL1: ST3 beta-galactoside alpha-2,3-sialyltransferase 1
     evidenced by: QTL:173763; QTL:173764;
   • ST8SIA1: ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
     evidenced by: QTL:173461; QTL:173462; QTL:173463;
   • STAT1: Signal transducer and activator of transcription 1, 91kDa
     evidenced by: QTL:9983;
   • STAT5A: Signal transducer and activator of transcription 5A
     evidenced by: QTL:10269; QTL:10270; QTL:136258; QTL:18799;
   • SUN2: Sad1 and UNC84 domain containing 2
     evidenced by: QTL:41570;
   • SUPT3H: SPT3 homolog, SAGA and STAGA complex component
     evidenced by: QTL:175840; QTL:175841;
   • SWT1: SWT1, RNA endoribonuclease homolog
     evidenced by: QTL:173828;
   • SYN3: Synapsin III
     evidenced by: QTL:41198;
   • SYT3: Synaptotagmin 3
     evidenced by: QTL:49869;
   • SYTL5: Synaptotagmin like 5
     evidenced by: QTL:54981;
   • TBC1D1: TBC1 domain family member 1
     evidenced by: QTL:172750;
   • TBC1D9: TBC1 domain family member 9
     evidenced by: QTL:48961;
   • TBCD: Tubulin folding cofactor D
     evidenced by: QTL:173831;
   • TDRKH: Tudor and KH domain containing
     evidenced by: QTL:57263;
   • TENM2: Teneurin transmembrane protein 2
     evidenced by: QTL:43305;
   • TG: Thyroglobulin
     evidenced by: QTL:173768; QTL:173769; QTL:31671;
   • TGM2: Transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)
     evidenced by: QTL:16182;
   • TLR4: Toll-like receptor 4
     evidenced by: QTL:136231; QTL:14033; QTL:167138; QTL:167143; QTL:167148; QTL:256619;
   • TMC5: Transmembrane channel like 5
     evidenced by: QTL:52542;
   • TNFSF10: Tumor necrosis factor (ligand) superfamily, member 10
     evidenced by: QTL:16209;
   • TPCN1: Two pore segment channel 1
     evidenced by: QTL:49389;
   • TRAPPC9: Trafficking protein particle complex 9
     evidenced by: QTL:161773; QTL:161774; QTL:161775; QTL:161776; QTL:161777; QTL:161778; QTL:161779; QTL:161780; QTL:161781; QTL:161782; QTL:166951; QTL:166953; QTL:166982; QTL:166984; QTL:166989; QTL:166999; QTL:173666; QTL:173667; QTL:173668; QTL:173669; QTL:173670; QTL:173671; QTL:173672; QTL:173673; QTL:173674; QTL:173675; QTL:173676; QTL:173677; QTL:173678; QTL:173679; QTL:32845; QTL:32846; QTL:32847; QTL:32848; QTL:32849; QTL:32850; QTL:32851; QTL:32852; QTL:32877; QTL:32889; QTL:32890; QTL:32891; QTL:32895; QTL:32901; QTL:32902; QTL:32909; QTL:32914; QTL:32915; QTL:32916; QTL:32917; QTL:32918; QTL:32919; QTL:32920; QTL:32921; QTL:32922; QTL:32959; QTL:33014; QTL:33017; QTL:33086; QTL:33087; QTL:33088; QTL:33089; QTL:33090; QTL:33091; QTL:33092; QTL:33093; QTL:33094; QTL:33095; QTL:33096; QTL:33127; QTL:33128; QTL:33130; QTL:33161; QTL:33201; QTL:33212; QTL:33219; QTL:33220; QTL:33225; QTL:33226; QTL:33247; QTL:33265; QTL:33294; QTL:33303; QTL:33304; QTL:33305; QTL:33306; QTL:33313; QTL:33320; QTL:33321; QTL:33353; QTL:33439; QTL:33451; QTL:33462; QTL:33467; QTL:33471; QTL:33479; QTL:33480; QTL:33481; QTL:33482; QTL:33483; QTL:33484; QTL:33485; QTL:33517; QTL:33526; QTL:33581; QTL:33589; QTL:33664; QTL:33665; QTL:34402; QTL:47469; QTL:47482; QTL:47493;
   • TRIM68: Tripartite motif containing 68
     evidenced by: QTL:47897;
   • TSHB: Thyroid stimulating hormone, beta
     evidenced by: QTL:57264;
   • TSNARE1: T-SNARE domain containing 1
     evidenced by: QTL:173629; QTL:173630; QTL:173631; QTL:173632; QTL:285913; QTL:34177; QTL:34178; QTL:34179; QTL:34245; QTL:34246; QTL:34435; QTL:34436; QTL:34553; QTL:34554; QTL:34555; QTL:34658; QTL:34669; QTL:34927; QTL:34928;
   • TSPAN32: Tetraspanin 32
     evidenced by: QTL:13547;
   • TTC33: Tetratricopeptide repeat domain 33
     evidenced by: QTL:173902;
   • UGDH: UDP-glucose 6-dehydrogenase
     evidenced by: QTL:25191; QTL:25192;
   • UGT1A6: UDP glucuronosyltransferase 1 family, polypeptide A6
     evidenced by: QTL:16158;
   • VIPR2: Vasoactive intestinal peptide receptor 2
     evidenced by: QTL:65677;
   • VPS13B: Vacuolar protein sorting 13 homolog B (yeast)
     evidenced by: QTL:173795; QTL:173796; QTL:173797; QTL:173798; QTL:175829; QTL:214843;
   • VPS28: VPS28, ESCRT-I subunit
     evidenced by: QTL:161784; QTL:166934; QTL:173582; QTL:47442;
   • WDPCP: WD repeat containing planar cell polarity effector
     evidenced by: QTL:35041; QTL:35042; QTL:35055;
   • WDR17: WD repeat domain 17
     evidenced by: QTL:53302;
   • WWC3: WWC family member 3
     evidenced by: QTL:55574; QTL:55592;
   • ZBP1: Z-DNA binding protein 1
     evidenced by: QTL:47297;
   • ZBTB39: Zinc finger and BTB domain containing 39
     evidenced by: QTL:40966;
   • ZC3H3: Zinc finger CCCH-type containing 3
     evidenced by: QTL:161785; QTL:161786; QTL:166942; QTL:166960; QTL:173602; QTL:173603; QTL:32833; QTL:32834; QTL:33222; QTL:34109; QTL:34168;
   • ZDHHC17: Zinc finger DHHC-type containing 17
     evidenced by: QTL:33579;
   • ZFAT: Zinc finger and AT-hook domain containing
     evidenced by: QTL:33343; QTL:33468; QTL:33469; QTL:33532; QTL:33747; QTL:33970; QTL:33971; QTL:33972; QTL:33973;
   • ZKSCAN8: Zinc finger with KRAB and SCAN domains 8
     evidenced by: QTL:52177;
   • ZMYND11: Zinc finger MYND-type containing 11
     evidenced by: QTL:34504; QTL:34665;
   • ZNF16: Zinc finger protein 16
     evidenced by: QTL:173573; QTL:173574; QTL:33156; QTL:33157; QTL:33158; QTL:33447;
   • ZNF335: Zinc finger protein 335
     evidenced by: QTL:47384;
   • ZNF34: Zinc finger protein 34
     evidenced by: QTL:33410; QTL:33411; QTL:33412;
   • ZNF407: Zinc finger protein 407
     evidenced by: QTL:52266;
   • ZNF45: Zinc finger protein 45
     evidenced by: QTL:49793;
   • ZNF484: Zinc finger protein 484
     evidenced by: QTL:173566;
   • ZNF592: Zinc finger protein 592
     evidenced by: QTL:51137;
   • ZNF696: Zinc finger protein 696
     evidenced by: QTL:173606;
   533 correlations are found involving Milk fat percentage
    

5. Trait name:	Subcutaneous fat percentage
   Ontology terms:	VT:0010045

   1 gene are associated with this trait, with QTL/association found

   • MSTN: Myostatin
     evidenced by: QTL:11884;